• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖谷氨酸盐包被的非离子表面活性剂囊泡:一种鼻脑递送的方案。

Chitosan Glutamate-Coated Niosomes: A Proposal for Nose-to-Brain Delivery.

作者信息

Rinaldi Federica, Hanieh Patrizia N, Chan Lik King Nicholas, Angeloni Livia, Passeri Daniele, Rossi Marco, Wang Julie Tzu-Wen, Imbriano Anna, Carafa Maria, Marianecci Carlotta

机构信息

Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia (ITT), Viale Regina Elena 291, 00161 Rome, Italy.

Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P.zzle A. Moro 5, 00185 Roma, Italy.

出版信息

Pharmaceutics. 2018 Mar 22;10(2):38. doi: 10.3390/pharmaceutics10020038.

DOI:10.3390/pharmaceutics10020038
PMID:29565809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6027090/
Abstract

The aim of this in vitro study is to prepare and characterize drug free and pentamidine loaded chitosan glutamate coated niosomes for intranasal drug delivery to reach the brain through intranasal delivery. Mucoadhesive properties and stability testing in various environments were evaluated to examine the potential of these formulations to be effective drug delivery vehicles for intranasal delivery to the brain. Samples were prepared using thin film hydration method. Changes in size and ζ-potential of coated and uncoated niosomes with and without loading of pentamidine in various conditions were assessed by dynamic light scattering (DLS), while size and morphology were also studied by atomic force microscopy (AFM). Bilayer properties and mucoadhesive behavior were investigated by fluorescence studies and DLS analyses, respectively. Changes in vesicle size and ζ-potential values were shown after addition of chitosan glutamate to niosomes, and when in contact with mucin solution. In particular, interactions with mucin were observed in both drug free and pentamidine loaded niosomes regardless of the presence of the coating. The characteristics of the proposed systems, such as pentamidine entrapment and mucin interaction, show promising results to deliver pentamidine or other possible drugs to the brain via nasal administration.

摘要

本体外研究的目的是制备并表征用于鼻内给药以通过鼻内递送到达脑部的无药物和载有喷他脒的壳聚糖谷氨酸包衣脂质体。评估了在各种环境中的粘膜粘附特性和稳定性测试,以检查这些制剂作为鼻内递送至脑部的有效药物递送载体的潜力。使用薄膜水化法制备样品。通过动态光散射(DLS)评估在各种条件下有和没有负载喷他脒的包衣和未包衣脂质体的尺寸和ζ电位的变化,同时还通过原子力显微镜(AFM)研究尺寸和形态。分别通过荧光研究和DLS分析研究双层性质和粘膜粘附行为。在向脂质体中加入壳聚糖谷氨酸后以及与粘蛋白溶液接触时,显示出囊泡大小和ζ电位值的变化。特别是,无论是否存在包衣,在无药物和载有喷他脒的脂质体中均观察到与粘蛋白的相互作用。所提出的系统的特性,如喷他脒包封和与粘蛋白的相互作用,显示出通过鼻腔给药将喷他脒或其他可能的药物递送至脑部的有希望的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/70e2b9ed8ca8/pharmaceutics-10-00038-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/e1ca9198c5f7/pharmaceutics-10-00038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/1f253e7f9477/pharmaceutics-10-00038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/64fadd2c67ed/pharmaceutics-10-00038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/dd54579b635a/pharmaceutics-10-00038-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/7bcd479e47da/pharmaceutics-10-00038-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/ec3b2d48c6f8/pharmaceutics-10-00038-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/e18dc3eaadb4/pharmaceutics-10-00038-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/f408472d15c0/pharmaceutics-10-00038-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/69fdd0c5b0f4/pharmaceutics-10-00038-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/70e2b9ed8ca8/pharmaceutics-10-00038-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/e1ca9198c5f7/pharmaceutics-10-00038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/1f253e7f9477/pharmaceutics-10-00038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/64fadd2c67ed/pharmaceutics-10-00038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/dd54579b635a/pharmaceutics-10-00038-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/7bcd479e47da/pharmaceutics-10-00038-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/ec3b2d48c6f8/pharmaceutics-10-00038-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/e18dc3eaadb4/pharmaceutics-10-00038-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/f408472d15c0/pharmaceutics-10-00038-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/69fdd0c5b0f4/pharmaceutics-10-00038-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/6027090/70e2b9ed8ca8/pharmaceutics-10-00038-g010.jpg

相似文献

1
Chitosan Glutamate-Coated Niosomes: A Proposal for Nose-to-Brain Delivery.壳聚糖谷氨酸盐包被的非离子表面活性剂囊泡:一种鼻脑递送的方案。
Pharmaceutics. 2018 Mar 22;10(2):38. doi: 10.3390/pharmaceutics10020038.
2
Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures.载有拉科酰胺并涂覆有壳聚糖的新型鼻腔脂质体:一种靶向大脑以控制部分性发作的可能途径。
Int J Pharm X. 2023 Aug 12;6:100206. doi: 10.1016/j.ijpx.2023.100206. eCollection 2023 Dec 15.
3
inPentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice.在 Pentasomes 中:一种创新的鼻腔至脑部戊二脒传递系统可减轻小鼠的 MPTP 帕金森病。
J Control Release. 2019 Jan 28;294:17-26. doi: 10.1016/j.jconrel.2018.12.007. Epub 2018 Dec 7.
4
Optimized Mucoadhesive Coated Niosomes as a Sustained Oral Delivery System of Famotidine.优化的黏附性包衣奈米脂质体作为法莫替丁的持续口服递药系统。
AAPS PharmSciTech. 2017 Nov;18(8):3064-3075. doi: 10.1208/s12249-017-0780-7. Epub 2017 May 17.
5
Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.用于经鼻途径脑递送的5-羟色胺受体激动剂盐酸丁螺环酮的脂质体原位鼻腔凝胶的制剂与评价
Pharm Nanotechnol. 2018;6(1):69-78. doi: 10.2174/2211738506666180130105919.
6
Systematic optimization of cationic surface engineered mucoadhesive vesicles employing Design of Experiment (DoE): A preclinical investigation.采用实验设计(DoE)对阳离子表面工程化的黏附性囊泡进行系统优化:一项临床前研究。
Int J Biol Macromol. 2019 Jul 15;133:1142-1155. doi: 10.1016/j.ijbiomac.2019.04.118. Epub 2019 Apr 17.
7
Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and evaluation.经鼻腔给药的奥氮平表面修饰的尼莫司汀囊泡:制备、优化和评价。
J Liposome Res. 2020 Jun;30(2):163-173. doi: 10.1080/08982104.2019.1610435. Epub 2019 May 22.
8
Preparation and Characterization of Mucoadhesive Loratadine Nanoliposomes for Intranasal Administration.用于鼻内给药的粘膜粘附性氯雷他定纳米脂质体的制备与表征
Turk J Pharm Sci. 2021 Sep 1;18(4):492-497. doi: 10.4274/tjps.galenos.2020.33254.
9
New Peceol™/Span™ 60 Niosomes Coated with Chitosan for Candesartan Cilexetil: Perspective Increase in Absolute Bioavailability in Rats.新型 Peceol™/Span™ 60 胆固醇脂质体包被壳聚糖用于坎地沙坦西酯:提高大鼠绝对生物利用度的新视角。
Int J Nanomedicine. 2021 Aug 16;16:5581-5601. doi: 10.2147/IJN.S324171. eCollection 2021.
10
Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery.用于鼻脑给药的BNN27粘膜粘附脂质体和纳米乳剂的开发及体外和体内比较研究
Pharmaceutics. 2023 Jan 27;15(2):419. doi: 10.3390/pharmaceutics15020419.

引用本文的文献

1
Preparation, and ex vivo and in vivo Characterization of Favipiravir-Loaded Aspasomes and Niosomes for Nose-to-Brain Administration.用于鼻脑给药的载法匹拉韦阿帕索姆和非离子表面活性剂囊泡的制备及其体外和体内表征
Int J Nanomedicine. 2025 May 22;20:6489-6514. doi: 10.2147/IJN.S518486. eCollection 2025.
2
Repurposing the anti-parasitic agent pentamidine for cancer therapy; a novel approach with promising anti-tumor properties.将抗寄生虫药物喷他脒重新用于癌症治疗;一种具有前景的抗肿瘤特性的新方法。
J Transl Med. 2025 Mar 3;23(1):258. doi: 10.1186/s12967-025-06293-w.
3
Nose to brain strategy coupled to nano vesicular system for natural products delivery: Focus on synaptic plasticity in Alzheimer's disease.

本文引用的文献

1
Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia.载有胃饥饿素的包衣脂质体用于鼻脑给药治疗恶病质的研发。
Int J Nanomedicine. 2017 Nov 28;12:8531-8543. doi: 10.2147/IJN.S147650. eCollection 2017.
2
Polymer coated mucoadhesive liposomes intended for the management of xerostomia.用于治疗口干症的聚合物包衣粘膜粘附脂质体。
Int J Pharm. 2017 Jul 15;527(1-2):72-78. doi: 10.1016/j.ijpharm.2017.05.032. Epub 2017 May 15.
3
Niosomal approach to brain delivery: Development, characterization and in vitro toxicological studies.
用于天然产物递送的鼻脑给药策略与纳米囊泡系统相结合:聚焦阿尔茨海默病中的突触可塑性
J Pharm Anal. 2024 Dec;14(12):101057. doi: 10.1016/j.jpha.2024.101057. Epub 2024 Aug 5.
4
Enhancing Acute Migraine Treatment: Exploring Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for the Nose-to-Brain Route.增强急性偏头痛治疗:探索用于鼻脑途径的固体脂质纳米粒和纳米结构脂质载体。
Pharmaceutics. 2024 Oct 4;16(10):1297. doi: 10.3390/pharmaceutics16101297.
5
Functional Evaluation of Niosomes Utilizing Surfactants in Nanomedicine Applications.利用纳米医学应用中的表面活性剂的尼欧索米的功能评估。
Int J Nanomedicine. 2024 Oct 10;19:10283-10305. doi: 10.2147/IJN.S480639. eCollection 2024.
6
An Overview on the Physiopathology of the Blood-Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery.血脑屏障的病理生理学及用于中枢神经系统给药的脂质纳米载体概述
Pharmaceutics. 2024 Jun 22;16(7):849. doi: 10.3390/pharmaceutics16070849.
7
Multi-cohort comprehensive analysis unveiling the clinical value and therapeutic effect of in glioma.多队列综合分析揭示在神经胶质瘤中的临床价值和治疗效果。
Oncol Res. 2024 Apr 23;32(5):965-981. doi: 10.32604/or.2024.045769. eCollection 2024.
8
Exploring Potential of Nano-formulations in the Treatment of Alzheimer's Disease through Nasal Route.探索纳米制剂经鼻途径治疗阿尔茨海默病的潜力。
Curr Alzheimer Res. 2024;21(10):693-709. doi: 10.2174/0115672050290462240222092303.
9
Tyrosol-loaded Nano-niosomes Attenuate Diabetic Injury by TargetingGlucose Metabolism, Inflammation, and Glucose Transfer.没食子醇负载的纳米奈脂质体通过靶向葡萄糖代谢、炎症和葡萄糖转运来减轻糖尿病损伤。
Pharm Nanotechnol. 2024;12(4):351-364. doi: 10.2174/0122117385251271231018104311.
10
Nanotechnology-based Nose-to-brain Delivery in Epilepsy: A NovelApproach to Diagnosis and Treatment.基于纳米技术的经鼻脑递药在癫痫中的应用:一种新的诊断和治疗方法。
Pharm Nanotechnol. 2024;12(4):314-328. doi: 10.2174/0122117385265554230919070402.
用于脑递送的脂质体方法:开发、表征及体外毒理学研究。
Int J Pharm. 2016 Sep 25;511(2):969-82. doi: 10.1016/j.ijpharm.2016.08.002. Epub 2016 Aug 3.
4
Release Pattern of Liposomal Bupivacaine in Artificial Cerebrospinal Fluid.脂质体布比卡因在人工脑脊液中的释放模式。
Turk J Anaesthesiol Reanim. 2016 Feb;44(1):1-6. doi: 10.5152/TJAR.2016.02438. Epub 2016 Feb 1.
5
Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes.不同类型表面活性剂对卡维地洛纳米囊泡物理性质及稳定性的影响
Adv Biomed Res. 2016 Mar 16;5:48. doi: 10.4103/2277-9175.178781. eCollection 2016.
6
S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease.S100B抑制剂喷他脒可减轻阿尔茨海默病小鼠模型中的反应性胶质增生并减少神经元损失。
Biomed Res Int. 2015;2015:508342. doi: 10.1155/2015/508342. Epub 2015 Jul 29.
7
S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells.喷他脒介导的S100B与p53解离通过抑制水通道蛋白4和金属蛋白酶2促进C6胶质瘤细胞凋亡并抑制细胞迁移。
Oncol Lett. 2015 Jun;9(6):2864-2870. doi: 10.3892/ol.2015.3091. Epub 2015 Apr 1.
8
Probing the Mucoadhesive Interactions Between Porcine Gastric Mucin and Some Water-Soluble Polymers.探究猪胃粘蛋白与某些水溶性聚合物之间的粘膜粘附相互作用
Macromol Biosci. 2015 Nov;15(11):1546-53. doi: 10.1002/mabi.201500158. Epub 2015 Jun 23.
9
Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery.壳聚糖作为一种适用于抗阿尔茨海默病药物递送的纳米载体材料。
Int J Biol Macromol. 2015 Jan;72:454-65. doi: 10.1016/j.ijbiomac.2014.08.052. Epub 2014 Sep 6.
10
Structure of chitosan determines its interactions with mucin.壳聚糖的结构决定了它与黏蛋白的相互作用。
Biomacromolecules. 2014 Oct 13;15(10):3550-8. doi: 10.1021/bm5007954. Epub 2014 Sep 4.